Skip to main content
. 2020 Sep 6;9(18):e014505. doi: 10.1161/JAHA.119.014505

Table 1.

Clinical Characteristics, Aortic Segments With Penetrating Aortic Ulcers, Baseline Morphological Findings, and Laboratory Examinations (n=109)

Characteristic
Demographic and clinical data
Age, y 65.21±10.09
Men 87 (79.82)
BMI, kg/m2 24.96±3.31
Systemic hypertension 88 (80.73)
Smoking 78 (71.56)
Hyperlipidemia 36 (33.03)
Diabetes mellitus 10 (9.17)
Coronary heart disease 37 (33.94)
Imaging
Mean number of penetrating atherosclerotic ulcers 1.15±0.40
Aortic arch 33 (30.28)
Descending thoracic aorta 72 (66.06)
Abdominal aorta 4 (3.67)
Mean ulcer diameter, mm 11.31±5.44
Mean ulcer depth, mm 8.19±4.50
Maximum ascending aorta diameter, mm 43.08±4.84
Maximum descending aorta diameter, mm 30.37±5.62
Pleural effusion 33 (30.28)
Pericardial effusion 1 (0.92)
Medical
Antiplatelet agents 5 (4.59)
Beta‐blockers 8 (7.34)
Calcium antagonists 35 (32.11)
ACE inhibitors 5 (4.59)
ARB inhibitors 16 (14.68)
Nitrates 4 (3.67)
Statins 5 (4.59)
Systolic BP, mm Hg 150.07±24.18
Diastolic BP, mm Hg 85.74±13.24
Heart rate, BPM 79.01±10.46
Laboratory examinations
CKMB, ng/mL 11.00 (8.50, 15.50)
TNT exception 33 (30.28)
ALT, U/L 16.20 (12.00, 23.30)
AST, U/L 18.00 (14.54, 24.01)
WBC, 109/L 9.97±2.72
PLT, 109/L 206.00 (178.50, 253.00)
HG, g/L 133.09±17.43
BUN, mmol/L 6.36 (4.97, 9.34)
CR, μmol/L 81.10 (68.60, 103.00)
C‐reactive protein, mg/dL 49.30 (19.50, 62.90)
D‐dimer, ng/mL 1.60 (0.80, 2.85)

Data are expressed as mean±SD, medians (25th percentiles, 75th percentiles), or number (percentage). ACE indicates angiotensin‐converting enzyme; ALT, alanine aminotransferase; ARB, angiotensin receptor blocker; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; BPM, beat per minute; BUN, blood urea nitrogen; CKMB, creatine phosphokinase‐myocardial band; CR, creatinine; HG, hemoglobin; PLT, platelet count; TNT, troponin‐T; and WBC, white blood cell.